Literature DB >> 29717522

Brain morphologic changes in early stages of psychosis: Implications for clinical application and early intervention.

Tsutomu Takahashi1, Michio Suzuki1.   

Abstract

To date, a large number of magnetic resonance imaging (MRI) studies have been conducted in schizophrenia, which generally demonstrate gray matter reduction, predominantly in the frontal and temporo-limbic regions, as well as gross brain abnormalities (e.g., a deviated sulcogyral pattern). Although the causes as well as timing and course of these findings remain elusive, these morphologic changes (especially gross brain abnormalities and medial temporal lobe atrophy) are likely present at illness onset, possibly reflecting early neurodevelopmental abnormalities. In addition, longitudinal MRI studies suggest that patients with schizophrenia and related psychoses also have progressive gray matter reduction during the transition period from prodrome to overt psychosis, as well as initial periods after psychosis onset, while such changes may become almost stable in the chronic stage. These active brain changes during the early phases seem to be relevant to the development of clinical symptoms in a region-specific manner (e.g., superior temporal gyrus atrophy and positive psychotic symptoms), but may be at least partly ameliorated by antipsychotic medication. Recently, increasing evidence from MRI findings in individuals at risk for developing psychosis has suggested that those who subsequently develop psychosis have baseline brain changes, which could be at least partly predictive of later transition into psychosis. In this article, we selectively review previous MRI findings during the course of psychosis and also refer to the possible clinical applicability of these neuroimaging research findings, especially in the diagnosis of schizophrenia and early intervention for psychosis.
© 2018 The Authors. Psychiatry and Clinical Neurosciences © 2018 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  at-risk mental state; magnetic resonance imaging; neuroimaging; psychosis; schizophrenia

Mesh:

Year:  2018        PMID: 29717522     DOI: 10.1111/pcn.12670

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  21 in total

1.  Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State.

Authors:  Daiki Sasabayashi; Yoichiro Takayanagi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Chika Obara; Masahiro Katsura; Naohiro Okada; Shinsuke Koike; Hidenori Yamasue; Mihoko Nakamura; Atsushi Furuichi; Mikio Kido; Yumiko Nishikawa; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; Kiyoto Kasai; Michio Suzuki
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

2.  Reduced Cortical Thickness in Schizophrenia and Schizotypal Disorder.

Authors:  Yoichiro Takayanagi; Daiki Sasabayashi; Tsutomu Takahashi; Atsushi Furuichi; Mikio Kido; Yumiko Nishikawa; Mihoko Nakamura; Kyo Noguchi; Michio Suzuki
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

3.  Different Heschl's Gyrus Duplication Patterns in Deficit and Non-deficit Subtypes of Schizophrenia.

Authors:  Tsutomu Takahashi; Daiki Sasabayashi; Yoichiro Takayanagi; Atsushi Furuichi; Haruko Kobayashi; Kyo Noguchi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2022-06-16       Impact factor: 5.435

4.  Frontotemporal thalamic connectivity in schizophrenia and schizotypal personality disorder.

Authors:  Philip R Szeszko; Suril Gohel; Daniel H Vaccaro; King-Wai Chu; Cheuk Y Tang; Kim E Goldstein; Antonia S New; Larry J Siever; Margaret McClure; M Mercedes Perez-Rodriguez; M Mehmet Haznedar; William Byne; Erin A Hazlett
Journal:  Psychiatry Res Neuroimaging       Date:  2022-02-19       Impact factor: 2.493

5.  Volume Reduction of the Dorsal Lateral Prefrontal Cortex Prior to the Onset of Frank Psychosis in Individuals with an At-Risk Mental State.

Authors:  Yoichiro Takayanagi; Sue Kulason; Daiki Sasabayashi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Noriyuki Ohmuro; Masahiro Katsura; Shimako Nishiyama; Mikio Kido; Atsushi Furuichi; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; J Tilak Ratnanather; Michio Suzuki
Journal:  Cereb Cortex       Date:  2022-05-14       Impact factor: 4.861

6.  The clinical relevance of gray matter atrophy and microstructural brain changes across the psychosis continuum.

Authors:  Faith M Hanlon; Andrew B Dodd; Josef M Ling; Nicholas A Shaff; David D Stephenson; Juan R Bustillo; Shannon F Stromberg; Denise S Lin; Sephira G Ryman; Andrew R Mayer
Journal:  Schizophr Res       Date:  2021-02-17       Impact factor: 4.939

7.  Pituitary Volume and Socio-Cognitive Functions in Individuals at Risk of Psychosis and Patients With Schizophrenia.

Authors:  Tsutomu Takahashi; Yuko Higuchi; Yuko Komori; Shimako Nishiyama; Yoichiro Takayanagi; Daiki Sasabayashi; Mikio Kido; Atsushi Furuichi; Yumiko Nishikawa; Mihoko Nakamura; Kyo Noguchi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2018-11-09       Impact factor: 4.157

8.  Unraveling Diagnostic Biomarkers of Schizophrenia Through Structure-Revealing Fusion of Multi-Modal Neuroimaging Data.

Authors:  Evrim Acar; Carla Schenker; Yuri Levin-Schwartz; Vince D Calhoun; Tülay Adali
Journal:  Front Neurosci       Date:  2019-05-03       Impact factor: 4.677

9.  Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis.

Authors:  Felix L Nägele; Ofer Pasternak; Lisa V Bitzan; Marius Mußmann; Jonas Rauh; Marek Kubicki; Gregor Leicht; Martha E Shenton; Amanda E Lyall; Christoph Mulert
Journal:  World J Biol Psychiatry       Date:  2020-07-09       Impact factor: 4.132

Review 10.  Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.

Authors:  Ursula Werneke; Fiona Gaughran; David M Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.